Latest news
Loading news…
Okapi Sciences
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Heverlee, Vlaams-Brabant, Belgium Founded 2007 11-50 employees For Profit
Okapi Sciences is a Belgium-based company with a proprietary pet therapeutics antiviral platform and five clinical/development stage.
Okapi Sciences was acquired by Aratana Therapeutics in 2014 for $44M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 0
- Patents granted
- 2
- Trademarks
- 0
- Top patent class
- a61
Company Info
- Founded
- 2007
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- HQ
- Heverlee, Vlaams-Brabant, Belgium
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Jan 6, 2014
- Closed
- Jan 6, 2014
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -1.2
- Trend (90d)
- -0.1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Okapi Sciences
Loading news…
FAQs about Okapi Sciences
People who checked this page also checked these
Browse the full Acquirezy directory.